Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Shayla Hesse"'
Autor:
Shayla Hesse, Natalia Malachowa, Adeline R. Porter, Brett Freedman, Scott D. Kobayashi, Donald J. Gardner, Dana P. Scott, Sankar Adhya, Frank R. DeLeo
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
Infections caused by multidrug-resistant K. pneumoniae
Externí odkaz:
https://doaj.org/article/aebcf3ef228d47a7adcfddd0af92f87a
Autor:
Shayla Hesse, Manoj Rajaure, Erin Wall, Joy Johnson, Valery Bliskovsky, Susan Gottesman, Sankar Adhya
Publikováno v:
mBio, Vol 11, Iss 1 (2020)
ABSTRACT The evolution of phage resistance poses an inevitable threat to the efficacy of phage therapy. The strategic selection of phage combinations that impose high genetic barriers to resistance and/or high compensatory fitness costs may mitigate
Externí odkaz:
https://doaj.org/article/4e041000c950464486454e9b28544844
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
Antibiotic management of infections with multidrug-resistant organisms (MDRO) represents a complex clinical challenge. We report here the first patient with a severe MDRO infection managed with assistance of a novel “real-time” 3-day high-through
Externí odkaz:
https://doaj.org/article/ee63eb18bade46dab7fac03f184271fa
Autor:
Gina A, Suh, Thomas P, Lodise, Pranita D, Tamma, Jane M, Knisely, Jose, Alexander, Saima, Aslam, Karen D, Barton, Erica, Bizzell, Katherine M C, Totten, Joseph L, Campbell, Benjamin K, Chan, Scott A, Cunningham, Katherine E, Goodman, Kerryl E, Greenwood-Quaintance, Anthony D, Harris, Shayla, Hesse, Anthony, Maresso, Veronique, Nussenblatt, David, Pride, Michael J, Rybak, Zoe, Sund, David, van Duin, Daria, Van Tyne, Robin, Patel
Publikováno v:
Antimicrobial agents and chemotherapy. 66(3)
Increasing antimicrobial resistance and medical device-related infections have led to a renewed interest in phage therapy as an alternative or adjunct to conventional antimicrobials. Expanded access and compassionate use cases have risen exponentiall
Autor:
Sankar Adhya, Shayla Hesse
Publikováno v:
Annual Review of Microbiology. 73:155-174
Burgeoning problems of antimicrobial resistance dictate that new solutions be developed to combat old foes. Use of lytic bacteriophages (phages) for the treatment of drug-resistant bacterial infections is one approach that has gained significant trac
Autor:
Frank R. DeLeo, Donald J. Gardner, Scott D. Kobayashi, Brett Freedman, Dana P. Scott, Sankar Adhya, Shayla Hesse, Natalia Malachowa, Adeline R. Porter
Publikováno v:
mBio, Vol 12, Iss 1 (2021)
mBio
mBio
Severe infections caused by multidrug-resistant Klebsiella pneumoniae sequence type 258 (ST258) highlight the need for new therapeutics with activity against this pathogen. Bacteriophage (phage) therapy is an alternative treatment approach for multid
Publikováno v:
Medical Mycology Case Reports, Vol 17, Iss C, Pp 8-10 (2017)
Medical Mycology Case Reports
Medical Mycology Case Reports
We present a case of an immunocompromised woman with fever, pulmonary infiltrates and multiple bronchoalveolar lavage (BAL) cultures positive for Penicillium citrinum with a concomitant high BAL galactomannan level. We report the results of Aspergill
Publikováno v:
Frontiers in Medicine, Vol 5 (2018)
Frontiers in Medicine
Frontiers in Medicine
Antibiotic management of infections with multidrug-resistant organisms (MDRO) represents a complex clinical challenge. We report here the first patient with a severe MDRO infection managed with assistance of a novel “real-time” 3-day high-through
Autor:
Sankar Adhya, Brett Freedman, Shayla Hesse, Scott D. Kobayashi, Frank R. DeLeo, Natalia Malachowa, Adeline R. Porter
Publikováno v:
Open Forum Infectious Diseases
Background Bacteriophage (phage) therapy is being considered as a treatment option for patients with multi-drug-resistant bacterial infections. However, there is a dearth of controlled clinical data to support therapeutic phage efficacy. As a first s
Publikováno v:
The American Journal of Medicine. 130:e341-e342